Bluejay Therapeutics

📍 San Francisco Bay Area, United States🗓 Founded 2020👥 11 employees💰 Last funded May 2024
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HDV infection.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2020
Founded
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2021–2024 · investors recorded per year
2021220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Bluejay Therapeutics?
Bluejay Therapeutics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Bluejay Therapeutics last raise funding?
The most recent investment in Bluejay Therapeutics recorded on gritt.io was in May 2024.
When was Bluejay Therapeutics founded?
Bluejay Therapeutics was founded in 2020.
What industry is Bluejay Therapeutics in?
Bluejay Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bluejay Therapeutics based?
Bluejay Therapeutics is headquartered in San Francisco Bay Area, United States.